Using Safe Calculated Low Power of Electrons to Cut, Analyze and Exterminate the Outer and Inner Biological Elements of SARS-CoV-2, MERS-CoV-2 and Influenza viruses in Vitro
Waleed Ezzat Madboly, Magdi Gebril Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief
Journal of Scientific Research and Reports · pp. 1–15 · Published 5 Jan 2022
10.9734/jsrr/2022/v28i130482Abstract
Background: The treatment of pneumonia viruses with antiviral drugs produced mild to severe side effects until the immune system worked against the invaded virus. Objective: Therefore, it is crucial to develop an efficient alternative therapy with lower side effects against infection of pneumonia viruses. Methods: We hereby designated a novel device termed a a Life Restoration Device (LRD to produce electric frequencies with lower potential. The electric frequencies cancan specifically destroy the nucleic acid materials and viral envelope rather than the plasma of the infected cell. Using a glass tube model the infected cells with propagated viruses were filled in the glass tube and two nickel-coated copper rods were inserted into both ends. Then the two rods were connected into the LRD. Lower potential electric frequencies were applied for 30 min and 60 min onto the infected cells. Results: The treatment of the infected cell culture of MERS-CoV and SARS-CoV-2 using LRD for 30 min significantly reduced the viral infectivity to 83% and 22% respectively. After 60 min of MERS-CoV and SARS-CoV-2 exposure to LRD, the infectivity reduced to 21% and 1% respectively. Additionally, based on the data of transmission electron microscopy of the H5N1 virus and electrophoretic patterns of different types of viruses, the nucleic acid materials of the treated viruses were reduced based on the non-treated viruses. The electric frequencies sensitivity produced by LRD can reduce the fluidity of the viral envelope rather than the plasma membrane of the infected cells. Conclusion: Treatment of pneumonia viruses with electric stimulation is a new alternative therapy but needs more investigations. The data obtained from this study is important to develop an effective alternative viral therapy.
Cited by 2
Rajarshi Roy, Md Fulbabu Sk, Omprakash Tanwar · Molecular Diversity · 2022
Hany M. Abd Abd El-Lateef, Tarek El-Dabea, Mai M. Khalaf · International Journal of Molecular Sciences · 2022
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.